Nicholas Piramal files anti cancer molecule patent
Nicholas Piramal India Ltd (NPIL) has filed its first patent for a new chemical entity (NCE) - an anti-cancer molecule NP102. The new molecule is a cyclin-dependent kinase 4 (CDK4) inhibitor. The
Nicholas Piramal India Ltd (NPIL) has filed its first patent for a new chemical entity (NCE) - an anti-cancer molecule NP102. The new molecule is a cyclin-dependent kinase 4 (CDK4) inhibitor. The